Senior National Account Manager
ZoetisFull Time
Senior (5 to 8 years), Expert & Leadership (9+ years)
PTC Therapeutics is a global commercial biopharmaceutical company. For over 25 years our team has been deeply committed to a unified purpose: Extending life’s moments for children and adults living with a rare disease.
At PTC, we cultivate an inclusive culture where everyone feels valued, respected, and empowered. We welcome candidates from all backgrounds to join our team, fostering a strong sense of belonging.
The Key Account Manager I is a field-based position that serves as a direct link between PTC and Health Care Providers (HCPs) and clients in the assigned geographic region. Collaborating closely with the Director, Key Accounts and General Manager for the assigned region, and other members of the sales team, the incumbent is directly responsible for representing PTC’s products to medical professionals within their assigned geography.
The incumbent handles all operational aspects of pharmaceutical sales and service including, but not limited to: generating sales, communication and promotion of the clinical and economic benefits of the product, building and maintaining successful relationships, educating health care staffs, and identifying new opportunities for commercial and scientific growth.
He/she works cross-functionally with internal departments and external resources on Sales related issues. The Key Account Manager follow procedures (SOPs) as appropriate.
Develops therapies for CNS disorders
Axsome Therapeutics develops therapies for central nervous system (CNS) disorders, focusing on conditions like major depressive disorder, treatment-resistant depression, and Alzheimer's agitation. Their main product, AXS-05, is an oral medication that works by blocking NMDA receptors in the brain, which helps regulate mood. This drug has shown positive results in clinical trials and has received special FDA status to speed up its approval process. Unlike many competitors, Axsome emphasizes addressing unmet medical needs in CNS disorders and aims to improve patient outcomes through rigorous research and development. The company's goal is to bring effective treatments to market, enhancing the quality of life for patients suffering from these conditions.